Director Corey Andrew Barr explains why the upcoming edition will be the fair’s boldest, most forward-looking chapter yet.
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities ...
This question serves as a basic introduction to the three major genome viewers. One gene, ADAM23, will be examined using all three sites so that the reader can gain an appreciation of the subtle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results